Q-omics provides the consensus-scored LINC02588 profile across patient tissues and cancer cell-line models. LINC02588 expression is associated with patient survival in 21 of 34 cancer types, with the highest sampling consensus in KIRC. Among the 18 cancer types available for tumor–normal comparison, LINC02588 is differentially expressed in 10, with the highest sampling consensus in COAD. Additionally, LINC02588 RNA expression shows 9,688 significant protein co-abundance associations, with the highest sampling consensus in GBM. Together, these results highlight KIRC, COAD, and GBM as cancer lineages where LINC02588 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC02588 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC02588 survival associations across molecular data types. LINC02588 RNA expression shows survival associations in the most cancer types (21). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC02588 RNA expression–survival associations across cancer types. High LINC02588 expression shows unfavorable associations in KIRC, CESC, LIHC, STAD, UVM and ACC. The KIRC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .004). Together, the overview and detailed table identify KIRC as the clearest survival context for LINC02588 RNA expression.
This table summarizes LINC02588 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 10. The strongest signals are observed in COAD for RNA.
This table ranks reproducible tumor–normal expression differences for LINC02588. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC02588 shows lower tumor expression in COAD and READ and higher tumor expression in LIHC, LUAD, LUSC and HNSC. The COAD box plot shows higher LINC02588 RNA expression in normal versus tumor tissue (log2 FC = −0.875, t-test p < 0.001).
This table shows molecular features associated with LINC02588 in patient tissues and cancer cell lines. In patient samples, LINC02588 shows the broadest associations at the RNA and protein expression levels, with GBM recurring as the lineage with the largest associated feature set.
